SCHEMBL1675261

SCHEMBL1675261

c1csc(CCNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 18/20 0.81
DYRK1A Q13627 13/20 0.81
CLK1 P49759 13/20 0.81
CLK2 P49760 10/20 0.81
DYRK1B Q9Y463 10/20 0.81
CLK3 P49761 9/20 0.81
CYP2D6 P10635 5/20 0.81
CYP2C19 P33261 5/20 0.81
ALDH1A1 P00352 4/20 0.81
HSD17B10 Q99714 4/20 0.81
LMNA P02545 2/20 0.81
CYP2C9 P11712 2/20 0.81
TSHR P16473 2/20 0.81
MAPK1 P28482 2/20 0.81
KDM4E B2RXH2 2/20 0.81
MAPT P10636 2/20 0.81
HPGD P15428 2/20 0.81
EGFR P00533 1/20 0.81
ALOX15 P16050 1/20 0.81
RECQL P46063 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29594697 0.90 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675086 0.90 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675327 0.82 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675243 0.82 CLK1 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675391 0.81 CLK4 (0.82) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675362 0.79 CLK1 (0.82) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675205 0.79 CLK4 (0.68) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675368 0.78 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675237 0.78 CLK4 (0.85) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675369 0.78 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed